A PYMNTS Company

Antitrust Chronicle® – Killer Acquisitions

Spring 2020, Volume 2, Number 2

Dear Readers, What is a killer acquisition? The term was first employed in the pharmaceutical sector to describe acquisitions by an incumbent of a competitor that threatened to launch a blockbuster drug that would undermine its own products, with a view to shutting it down. In recent times, the term has broadened to cover other […]

Read More

In case you missed it...



June

“Buy Now, Pay Later” (“BNPL”) has moved from fintech curiosity to embedded infrastructure in modern consumer markets, quietly reshaping how credit is extended, priced, and experienced. What began as a frictionless alternative to traditional lending now sits at the intersection of payments, consumer protection, and competition policy.




May

As health systems evolve beyond purely clinical data toward richer, more contextualized information environments, the integration of SDoH into AI systems raises a central tension: the same data that can improve equity and care delivery can also encode and obscure discrimination. The contributions in this issue begin to map that terrain.




April

This Chronicle explores the rapidly evolving intersection of foreign direct investment and technology, a space where traditional assumptions about openness, control, and market integration are being fundamentally reworked.


See more Chronicles by year: